﻿<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet title="XSL_formatting" type="text/xsl" href="cms1260795.aspx"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><language>en-gb</language><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><lastBuildDate>Sat, 11 Oct 2008 16:37:04 GMT</lastBuildDate><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><description><![CDATA[aidsmap.com news feed : aidsmap news]]></description><copyright>Copyright NAM 2008</copyright><link>http://www.aidsmap.com</link><atom:link href="http://www.aidsmap.com/cms1260794.aspx" rel="self" type="application/rss+xml" /><image><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><url>http://www.aidsmap.com/files/file1002517.gif</url><link>http://www.aidsmap.com</link><width>122</width><height>44</height></image><ttl>15</ttl><item><title><![CDATA[Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load]]></title><link>http://www.aidsmap.com/en/news/1005DE3B-85DF-4B12-9CC7-7EB47A79FD95.asp</link><author>Gus Cairns</author><guid isPermaLink="false">1005DE3B-85DF-4B12-9CC7-7EB47A79FD95</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[HIV post-exposure prophylaxis, even when it fails to prevent infection, may still have benefits, a case report in the  Journal of Acquired Immune Deficiency Syndromes suggests.
]]></description><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Jury still out on whether circumcision protects gay men against HIV]]></title><link>http://www.aidsmap.com/en/news/50E2ECDF-D17D-4195-91F6-57551AE84501.asp</link><author>Gus Cairns</author><guid isPermaLink="false">50E2ECDF-D17D-4195-91F6-57551AE84501</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[A meta-analysis of studies of circumcision in gay men and men who have sex with men (MSM) has not found sufficient evidence to show that being circumcised reduced their risk of acquiring HIV. Although it finds a small reduction in the risk of HIV infection in circumcised men, this is not statistically significant - in other words it could just be a chance finding. Furthermore, the study, published in the Journal of the American Medical Association, found that although circumcised men who were exclusively insertive for anal sex had a lower risk of infection with HIV, the difference with uncircumcised men was still not statistically significant and could have been chance.
]]></description><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Antiretroviral therapy does not fully reverse impact of HIV on hepatitis C-related cirrhosis]]></title><link>http://www.aidsmap.com/en/news/876ED37E-3B94-40F2-AFE2-3140E03C1DB7.asp</link><author>David McLay</author><guid isPermaLink="false">876ED37E-3B94-40F2-AFE2-3140E03C1DB7</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[In a meta-analysis of over 3500 patients co-infected with HIV and hepatitis C, Canadian researchers have found that the risk of hepatitis C-related cirrhosis has fallen since effective antiretroviral therapy became available. However, the report, published in the October 1st edition of AIDS, also notes that antiretroviral therapy does not fully counter the harmful impact HIV has on the liver of co-infected individuals.   
]]></description><category>Hepatitis news</category></item><item><title><![CDATA[High early mortality after starting antiretroviral treatment in Africa]]></title><link>http://www.aidsmap.com/en/news/3BADC5D7-D625-4B9B-B875-3D766B8DCD8D.asp</link><author>Kelly Morris</author><guid isPermaLink="false">3BADC5D7-D625-4B9B-B875-3D766B8DCD8D</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[Patients starting antiretroviral therapy in sub-Saharan Africa have a high rate of mortality, according to a review article published in the October 1st edition of AIDS. Many of the deaths occurred in the first three months of treatment, and there was also notable mortality in the interval between joining a treatment programme and actually starting therapy.
]]></description><category>Africa news</category><category>Palliative care news</category></item><item><title><![CDATA[Nobel prize awarded to French discoverers of HIV]]></title><link>http://www.aidsmap.com/en/news/DC84126A-9683-482C-8954-728DA265C6FF.asp</link><author>Michael Carter</author><guid isPermaLink="false">DC84126A-9683-482C-8954-728DA265C6FF</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[The French scientists who discovered HIV have been awarded the Nobel Prize for Medicine. The prize will be shared with the researcher who linked human papilloma virus and cervical cancer.
]]></description><category>Basic science news</category></item><item><title><![CDATA[Fall in number of undiagnosed HIV infections in the US]]></title><link>http://www.aidsmap.com/en/news/EEC288ED-49D4-4E4B-8111-9F696190B9BB.asp</link><author>Michael Carter</author><guid isPermaLink="false">EEC288ED-49D4-4E4B-8111-9F696190B9BB</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[Latest HIV prevalence figures show that there has been a fall in the number of undiagnosed HIV infections in the US. The figures, reported in the October 3rd edition of Morbidity and Mortality Weekly Report (MMWR), also show that there were just over 1,100,000 people living with HIV in the United States at the end of 2006. 
]]></description><category>Statistics and epidemiology news</category><category>World policy News</category></item><item><title><![CDATA[Resistance to darunavir related to pre-existing mutations]]></title><link>http://www.aidsmap.com/en/news/9938B4E7-FC17-46CE-BAEB-D89540C570D1.asp</link><author>Kelly Morris</author><guid isPermaLink="false">9938B4E7-FC17-46CE-BAEB-D89540C570D1</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[Pre-existing resistance may reduce the efficacy of the protease inhibitor darunavir, a study published in the September 12th edition of AIDS suggests. French investigators found that both baseline protease inhibitor resistance and darunavir treatment which did not fully suppress viral load were associated with the emergence of mutations conferring resistance to darunavir. The authors suggest guidelines to reduce development of darunavir resistance in people who have previously taken protease inhibitors.  
]]></description><category>Resistance news</category></item><item><title><![CDATA[Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis]]></title><link>http://www.aidsmap.com/en/news/5D43C654-A08D-40C8-8777-84DA318F9DD8.asp</link><author>Derek Thaczuk</author><guid isPermaLink="false">5D43C654-A08D-40C8-8777-84DA318F9DD8</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[In a meta-analysis of data from nearly 8000 patients reported in Clinical Infectious Diseases, researchers found significantly fewer drug resistance mutations, including NRTI-associated mutations, in people who had experienced treatment failure while taking first-line HIV treatment based on boosted PIs than in people taking NNRTI-based therapy. 
]]></description><category>Resistance news</category></item><item><title><![CDATA[Wide variation found in anal HPV viral loads in HIV-positive men]]></title><link>http://www.aidsmap.com/en/news/C3D22BCF-F462-4442-8D2F-BA01EB8CC0D5.asp</link><author>Derek Thaczuk</author><guid isPermaLink="false">C3D22BCF-F462-4442-8D2F-BA01EB8CC0D5</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[High rates of anal human papilloma virus infection have been found in an Italian cohort of HIV-positive men. A study, published in the October 1st edition of AIDS, also reports that the most common strains of human papilloma virus were those which carry a low risk of anal cancer. Human papilloma virus viral load was highly variable and did not appear to be linked to the strain of the virus or the strength of each individual patient’s immune system. 
]]></description><category>HIV and cancer news</category><category>HIV and sexual health news</category></item><item><title><![CDATA[Offering rapid point-of-care tests would increase uptake of HIV testing]]></title><link>http://www.aidsmap.com/en/news/B7016D27-144C-4C57-9126-42671B092BB5.asp</link><author>Roger Pebody</author><guid isPermaLink="false">B7016D27-144C-4C57-9126-42671B092BB5</guid><pubDate>Sat, 11 Oct 2008 16:37:04 GMT</pubDate><image /><description><![CDATA[Over half the people who decline to take an HIV test would do so if they had the option to take a test that gave the result in 20 minutes, report researchers in the August 2008 issue of the International Journal of STD and AIDS. The authors recommend that rapid point-of-care tests should be made routinely available in all genitourinary medicine (GUM) clinics.
]]></description><category>UK news</category><category>Developed world news</category><category>Prevention news</category></item></channel></rss>